414 related articles for article (PubMed ID: 33525077)
21. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
22. Does living donation have advantages over deceased donation in liver transplantation?
Kaido T; Uemoto S
J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
24. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
[TBL] [Abstract][Full Text] [Related]
26. Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.
Wan P; Zhang JJ; Li QG; Xu N; Zhang M; Chen XS; Han LZ; Xia Q
World J Gastroenterol; 2014 Apr; 20(15):4393-400. PubMed ID: 24764678
[TBL] [Abstract][Full Text] [Related]
27. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
[TBL] [Abstract][Full Text] [Related]
28. Liver transplantation for hepatocellular carcinoma: Korean experience.
Lee S; Ahn C; Ha T; Moon D; Choi K; Song G; Chung D; Park G; Yu Y; Choi N; Kim K; Kim K; Hwang S
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
[TBL] [Abstract][Full Text] [Related]
30. Improved Survival Following Living Donor Liver Transplantation for Pediatric Acute Liver Failure: Analysis of 20 Years of US National Registry Data.
Firl DJ; Sasaki K; McVey J; Hupertz V; Radhakrishnan K; Fujiki M; Eghtesad B; Miller CM; Quintini C; Hashimoto K
Liver Transpl; 2019 Aug; 25(8):1241-1250. PubMed ID: 31119826
[TBL] [Abstract][Full Text] [Related]
31. National experience with living donor liver transplantation for hepatocellular carcinoma.
Silverstein J; Yao FY; Grab JD; Braun HJ; Roberts J; Dodge JL; Mehta N
Liver Transpl; 2022 Jul; 28(7):1144-1157. PubMed ID: 35226793
[TBL] [Abstract][Full Text] [Related]
32. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
Hilmi IA; Damian D; Al-Khafaji A; Sakai T; Donaldson J; Winger DG; Kellum JA
Liver Transpl; 2015 Sep; 21(9):1179-85. PubMed ID: 25980614
[TBL] [Abstract][Full Text] [Related]
33. Clinical Impacts of Donor Types of Living vs. Deceased Donors: Predictors of One-Year Mortality in Patients with Liver Transplantation.
Kim EJ; Lim S; Chu CW; Ryu JH; Yang K; Park YM; Choi BH; Lee TB; Lee SJ
J Korean Med Sci; 2017 Aug; 32(8):1258-1262. PubMed ID: 28665060
[TBL] [Abstract][Full Text] [Related]
34. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
36. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
Wan P; Yu X; Xia Q
Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
[TBL] [Abstract][Full Text] [Related]
37. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
[TBL] [Abstract][Full Text] [Related]
38. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
39. Liver transplantation for HCC: its role: Eastern and Western perspectives.
Hwang S; Lee SG; Belghiti J
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):443-8. PubMed ID: 19885638
[TBL] [Abstract][Full Text] [Related]
40. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
